(주)리가켐 바이오사이언스

{
  "address": "대전광역시 유성구",
  "ceo_name": "김용주",
  "certificate": [
    {
      "cert_number": "20070200692",
      "changes": "",
      "disclosure_date": "2007-04-25",
      "first_cert_date": "2007-04-25",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2007-04-25 ~ 2008-04-24"
    },
    {
      "cert_number": "20080300217",
      "changes": "",
      "disclosure_date": "2008-05-15",
      "first_cert_date": "2007-04-25",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2008-04-25 ~ 2009-04-24"
    },
    {
      "cert_number": "20090300165",
      "changes": "",
      "disclosure_date": "2009-04-30",
      "first_cert_date": "2007-04-25",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2009-04-25 ~ 2010-04-24"
    },
    {
      "cert_number": "20100300136",
      "changes": "",
      "disclosure_date": "2010-04-22",
      "first_cert_date": "2007-04-25",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2010-04-25 ~ 2012-04-24"
    },
    {
      "cert_number": "20120300129",
      "changes": "",
      "disclosure_date": "2012-04-12",
      "first_cert_date": "2007-04-25",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2012-04-25 ~ 2014-04-24"
    },
    {
      "cert_number": "20140300146",
      "changes": "",
      "disclosure_date": "2014-04-10",
      "first_cert_date": "2007-04-25",
      "no": "6",
      "type": "벤처투자유형",
      "valid_period": "2014-04-25 ~ 2016-04-24"
    },
    {
      "cert_number": "20160300182",
      "changes": "",
      "disclosure_date": "2016-04-21",
      "first_cert_date": "2007-04-25",
      "no": "7",
      "type": "벤처투자유형",
      "valid_period": "2016-04-25 ~ 2018-04-24"
    },
    {
      "cert_number": "20180300254",
      "changes": "",
      "disclosure_date": "2018-04-12",
      "first_cert_date": "2007-04-25",
      "no": "8",
      "type": "벤처투자유형",
      "valid_period": "2018-04-25 ~ 2020-04-24"
    },
    {
      "cert_number": "20200300362",
      "changes": "",
      "disclosure_date": "2020-03-26",
      "first_cert_date": "2007-04-25",
      "no": "9",
      "type": "벤처투자유형",
      "valid_period": "2020-04-25 ~ 2022-04-24"
    },
    {
      "cert_number": "20220421010003",
      "changes": "",
      "disclosure_date": "2022-04-21",
      "first_cert_date": "2007-04-25",
      "no": "10",
      "type": "벤처투자유형",
      "valid_period": "2022-04-25 ~ 2025-04-24"
    },
    {
      "cert_number": "20250318010014",
      "changes": "",
      "disclosure_date": "2025-03-18",
      "first_cert_date": "2007-04-25",
      "no": "11",
      "type": "벤처투자유형",
      "valid_period": "2025-04-25 ~ 2028-04-24"
    }
  ],
  "company_name": "주식회사 리가켐바이오사이언스",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 13834372000,
      "cost_of_sales": 15563353000,
      "current_assets": 190648347000,
      "current_liabilities": 28581618000,
      "gross_profit": 17848690000,
      "net_income": -47434499000,
      "net_income_bs": -45424422000,
      "non_current_assets": 65570725000,
      "non_current_liabilities": 4300943000,
      "non_operating_expenses": 8066893000,
      "non_operating_income": 10663736000,
      "operating_profit": -50031342000,
      "revenue": 33412043000,
      "sga_expenses": 67880032000,
      "total_assets": 256219072000,
      "total_equity": 223336511000,
      "total_liabilities": 32882560000
    },
    "2023": {
      "capital_stock": 14210813000,
      "cost_of_sales": 16348326000,
      "current_assets": 133381234000,
      "current_liabilities": 37863751000,
      "gross_profit": 17797314000,
      "net_income": -76936847000,
      "net_income_bs": -74899863000,
      "non_current_assets": 59066301000,
      "non_current_liabilities": 3814113000,
      "non_operating_expenses": 9450676000,
      "non_operating_income": 13678322000,
      "operating_profit": -81164493000,
      "revenue": 34145640000,
      "sga_expenses": 98961807000,
      "total_assets": 192447535000,
      "total_equity": 150769671000,
      "total_liabilities": 41677864000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "30,000,000,000",
      "changes": "30,000,000,000",
      "date": "2021-08-30"
    },
    {
      "amount": "17,999,997,300",
      "changes": "17,999,997,300",
      "date": "2021-08-30"
    },
    {
      "amount": "12,983,317,000",
      "changes": "12,983,317,000",
      "date": "2019-04-18"
    }
  ],
  "main_products": "신약개발(항생제,항암제,ADC원천기술등)",
  "phone": "042-861-****",
  "years": [
    2023,
    2022
  ]
}